Cubist Systematic Strategies’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,710
Closed -$104K 3019
2025
Q1
$104K Sell
5,710
-781
-12% -$22.3K ﹤0.01% 2634
2024
Q4
$241K Buy
+6,491
New +$248K ﹤0.01% 2498
2024
Q2
Sell
-20,671
Closed -$3M 3081
2024
Q1
$3M Buy
20,671
+18,727
+963% +$1.58M 0.02% 1332
2023
Q4
$179K Buy
+1,944
New +$198K ﹤0.01% 3043
2023
Q3
Sell
-12,322
Closed -$779K 3387
2023
Q2
$779K Buy
12,322
+11,010
+839% +$667K 0.01% 2115
2023
Q1
$44.5K Sell
1,312
-684
-34% -$35.7K ﹤0.01% 3582
2022
Q4
$115K Sell
1,996
-12,103
-86% -$748K ﹤0.01% 3765
2022
Q3
$1.32M Buy
14,099
+2,427
+21% +$345K 0.01% 2371
2022
Q2
$2.6M Buy
11,672
+8,701
+293% +$2.91M 0.02% 1595
2022
Q1
$1.63M Buy
2,971
+897
+43% +$542K 0.01% 1653
2021
Q4
$1.37M Buy
2,074
+1,144
+123% +$875K 0.01% 1673
2021
Q3
$781K Sell
930
-2,260
-71% -$2.29M 0.01% 1714
2021
Q2
$4.05M Buy
3,190
+1,982
+164% +$2.24M 0.05% 657
2021
Q1
$1.32M Sell
1,208
-437
-27% -$577K 0.02% 1336
2020
Q4
$2.35M Buy
1,645
+1,385
+533% +$1.48M 0.03% 846
2020
Q3
$184K Buy
+260
New +$189K ﹤0.01% 2156
2020
Q2
Sell
-6,838
Closed -$2.39M 2399
2020
Q1
$2.39M Buy
6,838
+1,998
+41% +$1.42M 0.06% 412
2019
Q4
$3.04M Buy
4,840
+3,350
+225% +$1.64M 0.06% 528
2019
Q3
$499K Buy
1,490
+422
+40% +$135K 0.01% 1291
2019
Q2
$277K Buy
+1,068
New +$214K 0.01% 1862
2019
Q1
Sell
-1,138
Closed -$123K 2261
2018
Q4
$123K Buy
+1,138
New +$192K 0.01% 1713
2018
Q2
Sell
-1,828
Closed -$267K 1806
2018
Q1
$267K Buy
+1,828
New +$309K 0.02% 1222

Other funds holding CDLX

Cubist Systematic Strategies's CDLX Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 5,710 shares — an estimated $104K sold.

Cubist Systematic Strategies first reported a position in CDLX in Q1 2018 and held it in 22 quarters. The position peaked at $4.05M in Q2 2021. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 5,710 Cardlytics shares in Q2 2025, an estimated $104K.
  • Cubist Systematic Strategies first reported a position in Cardlytics in Q1 2018 and held it in 22 quarters.
  • Cubist Systematic Strategies's Cardlytics position peaked at $4.05M in Q2 2021.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.